Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -110,709 | -71,598 | -287,528 | -197,196 | -118,081 |
| Depreciation Amortization | 5,349 | 2,699 | 9,814 | 7,183 | 4,645 |
| Income taxes - deferred | 772 | -16 | -286 | 884 | 871 |
| Accounts receivable | -20,375 | -3,632 | -24,158 | -32,727 | -26,726 |
| Accounts payable and accrued liabilities | -1,840 | -1,173 | 1,300 | 8,816 | 3,395 |
| Other Working Capital | -9,599 | -16,504 | -51,989 | -52,972 | -40,620 |
| Other Operating Activity | 46,016 | 24,907 | 69,279 | 49,767 | 28,170 |
| Operating Cash Flow | $-90,386 | $-65,317 | $-283,568 | $-216,245 | $-148,346 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 167,652 | 98,839 | 185,590 | 99,932 | 51,888 |
| PPE Investments | -3,601 | -2,688 | -19,043 | -19,928 | -15,520 |
| Purchase Sale Intangibles | N/A | N/A | -8,089 | -8,089 | N/A |
| Other Investing Activity | 0 | 0 | -8,089 | -8,089 | 0 |
| Investing Cash Flow | $164,051 | $96,151 | $158,458 | $71,915 | $36,368 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -4,206 | -2,062 | -4,339 | -2,542 | -768 |
| Financing Cash Flow | $-4,203 | $-2,062 | $-4,339 | $-2,542 | $-768 |
| Exchange Rate Effect | -2,188 | -1,989 | 6,279 | 5,690 | 9,273 |
| Beginning Cash Position | 105,636 | 105,635 | 228,805 | 228,804 | 228,805 |
| End Cash Position | 172,910 | 132,418 | 105,635 | 87,622 | 125,332 |
| Net Cash Flow | $67,274 | $26,783 | $-123,170 | $-141,182 | $-103,473 |
| Free Cash Flow | |||||
| Operating Cash Flow | -90,386 | -65,317 | -283,568 | -216,245 | -148,346 |
| Capital Expenditure | -3,601 | -2,688 | -19,043 | -19,928 | -15,520 |
| Free Cash Flow | -93,987 | -68,005 | -302,611 | -236,173 | -163,866 |